Deferred Income Tax Assets, Net of HAEMONETICS CORP from 30 Mar 2019 to 27 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.
Summary
HAEMONETICS CORP quarterly Deferred Income Tax Assets, Net in USD history and change rate from 30 Mar 2019 to 27 Dec 2025.
  • HAEMONETICS CORP Deferred Income Tax Assets, Net for the quarter ending 27 Dec 2025 was $7,329,000, a 8.4% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Income Tax Assets, Net, Quarterly (USD)
Deferred Income Tax Assets, Net, YoY Quarterly Change (%)

HAEMONETICS CORP Quarterly Deferred Income Tax Assets, Net (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $7,329,000 -$671,000 -8.4% 27 Dec 2025 10-Q 05 Feb 2026 2026 Q3
Q3 2025 $7,571,000 -$1,512,000 -17% 27 Sep 2025 10-Q 06 Nov 2025 2026 Q2
Q2 2025 $7,843,000 -$1,526,000 -16% 28 Jun 2025 10-Q 07 Aug 2025 2026 Q1
Q1 2025 $7,803,000 +$64,000 +0.83% 29 Mar 2025 10-Q 05 Feb 2026 2026 Q3
Q4 2024 $8,000,000 +$2,930,000 +58% 28 Dec 2024 10-Q 06 Feb 2025 2025 Q3
Q3 2024 $9,083,000 +$4,338,000 +91% 28 Sep 2024 10-Q 07 Nov 2024 2025 Q2
Q2 2024 $9,369,000 +$4,494,000 +92% 29 Jun 2024 10-Q 08 Aug 2024 2025 Q1
Q1 2024 $7,739,000 +$2,498,000 +48% 30 Mar 2024 10-K 21 May 2025 2025 FY
Q4 2023 $5,070,000 +$228,000 +4.7% 30 Dec 2023 10-Q 08 Feb 2024 2024 Q3
Q3 2023 $4,745,000 +$463,000 +11% 30 Sep 2023 10-Q 02 Nov 2023 2024 Q2
Q2 2023 $4,875,000 +$323,000 +7.1% 01 Jul 2023 10-Q 08 Aug 2023 2024 Q1
Q1 2023 $5,241,000 +$773,000 +17% 01 Apr 2023 10-K 20 May 2024 2024 FY
Q4 2022 $4,842,000 -$1,208,000 -20% 31 Dec 2022 10-Q 07 Feb 2023 2023 Q3
Q3 2022 $4,282,000 -$1,782,000 -29% 01 Oct 2022 10-Q 08 Nov 2022 2023 Q2
Q2 2022 $4,552,000 -$1,645,000 -27% 02 Jul 2022 10-Q 10 Aug 2022 2023 Q1
Q1 2022 $4,468,000 -$1,541,000 -26% 02 Apr 2022 10-K 22 May 2023 2023 FY
Q4 2021 $6,050,000 +$1,492,000 +33% 01 Jan 2022 10-Q 08 Feb 2022 2022 Q3
Q3 2021 $6,064,000 +$1,758,000 +41% 02 Oct 2021 10-Q 09 Nov 2021 2022 Q2
Q2 2021 $6,197,000 +$2,109,000 +52% 03 Jul 2021 10-Q 11 Aug 2021 2022 Q1
Q1 2021 $6,009,000 +$2,079,000 +53% 03 Apr 2021 10-K 25 May 2022 2022 FY
Q4 2020 $4,558,000 26 Dec 2020 10-Q 02 Feb 2021 2021 Q3
Q3 2020 $4,306,000 26 Sep 2020 10-Q 04 Nov 2020 2021 Q2
Q2 2020 $4,088,000 27 Jun 2020 10-Q 04 Aug 2020 2021 Q1
Q1 2020 $3,930,000 -$429,000 -9.8% 28 Mar 2020 10-K 26 May 2021 2021 FY
Q1 2019 $4,359,000 30 Mar 2019 10-K 20 May 2020 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.